Press Releases from Greyston Research Associates (1 total)
Sustained Release Injectables to Exceed $10 Billion in 2015, According To Greyst …
(Amherst, NH) – Engineered formulations of injectable drugs – a class that includes established therapeutics for a number of disease segments including metabolic diseases, neurology…
Go To Page:
